Stay updated with breaking news from Ross Acquisition. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Denny Jacob Blank check company Ross Acquisition Corp. II shareholders approved amendments that would extend the date by which it must consummate a...
By Denny Jacob Blank check company Ross Acquisition Corp. II received a notice from the New York Stock Exchange's regulatory staff due to not being in...
The first special purpose acquisition company (SPAC) merger announced in 2023 has fallen apart. Aprinoia Therapeutics Inc. and Ross Acquisition Corp. II mutually agreed to call off the merger that had been valued at $280 million. The failed deal is part of a larger trend that has gained momentum in the past year as a struggling economy and tighter U.S. SEC restrictions dampened SPAC deals.
By Sabela Ojea Aprinoia Therapeutics and blank check firm Ross Acquisition on Wednesday said they mutually agreed to end their merger deal. The...
The deal with Ross Acquisition Corp. II values the combined company at about $320 million including debt.